Genetic alterations that disable G1/S checkpoint control and loss of this checkpoint often happen in human cancer. The mechanisms contribute to cancer generation by permitting inappropriate proliferation and distorting fate-driven cell cycle exit. Therefore, the active compounds activate the G1/S checkpoint. And they may represent a broadly applicable and...